Author:
Knapp Stefan,Sundström Michael
Subject
Drug Discovery,Pharmacology
Reference43 articles.
1. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug;Capdeville;Nat Rev Drug Discov,2002
2. A quantitative analysis of kinase inhibitor selectivity;Karaman;Nat Biotechnol,2008
3. Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis;Cervantes;Blood,2013
4. Ruxolitinib;Becker;Recent Results Cancer Res,2014
5. Do molecularly targeted agents in oncology have reduced attrition rates?;Walker;Nat Rev Drug Discov,2009
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献